Company Profile

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE8510.35-3.65 (-0.04 % )
PREV CLOSE (Rs.) 8514.00
OPEN PRICE (Rs.) 8504.10
BID PRICE (QTY) 8510.35 (1 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 296
TODAY'S LOW / HIGH (Rs.)8491.10 8537.50
52 WK LOW / HIGH (Rs.)6708.75 8834.05
NSE8519.70 7.75 (+0.09 % )
PREV CLOSE(Rs.) 8511.95
OPEN PRICE (Rs.) 8500.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 8519.70 (21 )
VOLUME 2493
TODAY'S LOW / HIGH(Rs.) 8500.00 8545.00
52 WK LOW / HIGH (Rs.)6666.25 8820.05

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.76
TTM EPS (Rs.) 211.93
P/E Ratio 40.16
Book Value (Rs.) 945.25
Face Value (Rs.) 10
MCap (Rs. in Mn) 180839.00
Price/Earning (TTM) 38.70
Price/Sales (TTM) 4.92
Price/Book (MRQ) 9.00
PAT Margin (%) 12.13
ROCE (%) 40.61
Incorporation Year : 1944

Management Info :

Munir Shaikh - Chairman Ambati Venu - Managing Director

Registered Office :

Address : Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone : 022- 67978888

Website : www.abbott.co.in

Registrar's Details : Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
14Jun06-14-2019$Abbott gains on unveiling sensor enabled HD grid mapping catheter Abbott gains on unveiling se

Abbott India is currently trading at Rs. 8613.00, up by 31.65 points or 0.37% from its previous closing of Rs. 8581.35 on the BSE.

The scrip opened at Rs. 8614.35 and has touched a high and low of Rs. 8620.00 and Rs. 8610.30 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 8834.05 on 10-Sep-2018 and a 52 week low of Rs. 6300.00 on 14-Jun-2018.

Last one week high and low of the scrip stood at Rs. 8670.00 and Rs. 7930.00 respectively. The current market cap of the company is Rs. 18304.89 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.04% and 15.98% respectively.

Abbott has unveiled sensor enabled HD grid mapping catheter, a device that can be inserted in the body to treat diseases or perform surgical procedures, in India.
The company has launched the product after receiving clearance from the US Food and Drug Administration (USFDA) last year.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.


Abbott India is currently trading at Rs. 8613.00, up by 31.65 p..
13Jun06-13-2019$Abbott unveils sensor enabled HD grid mapping catheter Abbott unveils sensor enable

Abbott has unveiled sensor enabled HD grid mapping catheter, a device that can be inserted in the body to treat diseases or perform surgical procedures, in India.

The company has launched the product after receiving clearance from the US Food and Drug Administration (USFDA) last year.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott has unveiled sensor enabled HD grid mapping catheter, a..
29May05-29-2019$Abbott India informs about compliance report Abbott India informs about c

Abbott India has informed that it has enclosed Annual Secretarial Compliance Report as on 31 st March 2019.

The above information is a part of company’s filings submitted to BSE.

Abbott India has informed that it has enclosed Annual Secretari..
02Apr04-02-2019$ Compliance Certificate For The Year Ended March 31, 2019 Compliance Certificate For
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Compliance Certificate dated April 2, 2019, duly signed by the Compliance Officer of the Company and Authorized Representative of the Registrar and Share Transfer Agent i.e., Karvy Fintech Private Limited for the year ended March 31, 2019.
Pursuant to Regulation 7(3) of the Securities and Exchange Boar..
01Apr04-01-2019$ Announcement under Regulation 30 (LODR)-Change in Directorate Announcement under Regulati
This is in furtherance to our letter dated march 30, 2019, intimating you about the appointments of Mr Sudarshan Jain as Independent Additional Director and Mr Mark Murphy II as Additional Director, effective April 1, 2019. In this regard, we hereby clarify that Mr Sudarshan Jain and his relatives hold 250 shares in the Company. You are requested to take the same on record.
This is in furtherance to our letter dated march 30, 2019, int..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit1131.94503.3
Gross Profit 1766 6988.5
Operating Profit 1822.67180.2
Net Sales 9063.136786
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Procter&Gamble Healt (BSE)
 3948.60 (2.48%)
M.Cap ( in Cr)
6554.43
Astrazeneca Pharma I (BSE)
 1886.40 (3.32%)
M.Cap ( in Cr)
4716.00
Dr. Reddys Lab (BSE)
 2590.00 (1.54%)
M.Cap ( in Cr)
43021.65
Torrent Pharma (BSE)
 1512.15 (0.97%)
M.Cap ( in Cr)
25586.90
IOL Chem & Pharma (BSE)
 192.05 (3.73%)
M.Cap ( in Cr)
1092.52
Shareholding Pattern More
PROMOTERS 74.99 %
MUTUAL FUNDS/UTI 5.63 %
NON-INSTITUTION 15.98 %
FI/BANKS/INSURANCE 0.81 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested